Needham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $143.00 (from $155.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE